MOOD — Doseology Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- CA$4.43m
- CA$3.50m
- CA$0.10m
- 53
- 10
- 60
- 35
Annual cashflow statement for Doseology Sciences, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.432 | -1.63 | -1.94 | -1.78 | -0.34 |
| Depreciation | |||||
| Non-Cash Items | — | 0.082 | 0.373 | 1.1 | 0.051 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.303 | -0.917 | -0.284 | 0.137 | 0.033 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.129 | -2.37 | -1.71 | -0.481 | -0.235 |
| Capital Expenditures | 0 | -0.146 | -0.006 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0.12 | -0.002 | 0 | — |
| Sale of Business | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.026 | -0.008 | 0 | — |
| Financing Cash Flow Items | 0 | -0.006 | 0.015 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.47 | 5.79 | -0.14 | -0.092 | -0.006 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.341 | 3.39 | -1.86 | -0.573 | -0.241 |